News & Articles

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

Which new products made the most difference to your lab work this year?

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Watch this webinar on demand to learn about the host immune response to COVID-19

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic

The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors

The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making

New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients

FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season

The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively